Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

Monthly Report: April 2026

April 2026 has been a month of significant strides in longevity science, with advancements ranging from innovative diagnostic tools to groundbreaking therapies. The spotlight this month shines on the integration of new technologies into existing health frameworks, aiming to enhance early disease detection and treatment personalization. Notably, 20/20 BioLabs has expanded its longevity testing capabilities by incorporating a chronic kidney disease prediction algorithm, underscoring the potential of precision medicine in extending healthspan.

What the science showed this month

Kidney Disease Prediction and Longevity Testing

20/20 BioLabs has made headlines by integrating a chronic kidney disease (CKD) prediction algorithm into its longevity test suite. This advancement, achieved through a partnership with ROKIT Healthcare, aims to identify individuals at risk of CKD earlier, potentially allowing for preventive measures that could extend healthspan. The algorithm, based on extensive data analytics, could revolutionize how we approach kidney health in the context of aging.

Aging and Lifestyle in Penguins

A fascinating study on king penguins has revealed that a sedentary lifestyle combined with abundant food availability accelerates their aging process. This research, conducted on zoo-housed penguins, highlights the impact of lifestyle factors on aging, suggesting parallels in human health. The findings emphasize the importance of maintaining an active lifestyle and balanced diet to mitigate aging-related changes, a concept that resonates with broader longevity strategies.

Gut Microbiome and Aging

Recent research has shown that fecal microbiota transplantation (FMT) from older mice to younger ones accelerates aging processes. This study sheds light on the significant role of the gut microbiome in aging, suggesting that manipulating gut bacteria could influence healthspan. These insights could pave the way for microbiome-based therapies aimed at slowing down aging and its associated diseases.

Food, movement, and daily habits

Japanese Eating Habits and Longevity

The traditional Japanese practice of hara hachi bu, which involves eating until one is 80% full, has been linked to enhanced longevity and healthspan. This approach to eating emphasizes moderation and mindfulness, potentially reducing the risk of obesity and related diseases. As more people seek sustainable dietary habits, this practice offers a simple yet effective strategy for promoting long-term health.

Exercise and Aging

The U.S. POINTER trial has provided compelling evidence that multidomain lifestyle interventions, including regular physical activity, significantly impact frailty indices among older adults. These findings reinforce the importance of a holistic approach to health that combines exercise, diet, and cognitive engagement to improve quality of life and longevity.

Sleep and Aging

Emerging research suggests that lighter sleep in older adults may not be a normal part of aging but rather a sign of underlying health issues. Understanding the neurobiology of sleep changes can help identify interventions to improve sleep quality, which is crucial for maintaining cognitive function and overall health as we age.

What might change how we age

Lilly’s Foundayo™ (orforglipron) has been approved as the first oral GLP-1 receptor agonist for weight management that can be taken without food or water restrictions. This approval marks a significant advancement in obesity treatment, offering a more convenient option for weight management.

Foundayo™ (orforglipron), now approved by the FDA, represents a breakthrough in weight management therapies, particularly for those struggling with obesity. As the first oral GLP-1 receptor agonist that can be taken at any time, it offers unprecedented flexibility and ease of use. This development could significantly impact public health by providing a more accessible treatment option for weight loss.

What this means for you

For those focused on longevity, this month’s findings highlight the importance of integrating technology and lifestyle changes into daily routines. The advancements in predictive diagnostics, such as the CKD prediction algorithm, emphasize the value of early detection and prevention in extending healthspan. Meanwhile, adopting practices like hara hachi bu and maintaining regular physical activity can contribute to a healthier, longer life. These insights underscore the need for a proactive approach to health, leveraging both modern science and traditional wisdom.

Who is building what

This month, significant investments and strategic partnerships have been announced, signaling robust growth in the longevity sector. Insilico Medicine’s collaboration with Eli Lilly, valued at up to $2.75 billion, highlights the increasing role of artificial intelligence in drug discovery. Meanwhile, Noom’s acquisition of Tailor Made Compounding reflects a strategic move to enhance its offerings in the healthy aging market. These developments suggest a strong focus on personalized medicine and technological integration in longevity research.

What to watch next month

Clinical Trials for Rapamycin: Ongoing studies aim to clarify dosing for its anti-aging effects, potentially influencing future therapeutic guidelines.
Advancements in Gut Microbiome Research: Continued exploration of microbiome-based therapies could offer new avenues for aging intervention.
Impact of New Weight Management Drugs: Observing the real-world application of Foundayo™ will provide insights into its effectiveness and acceptance.
Technological Innovations in Diagnostics: As companies like 20/20 BioLabs expand their testing capabilities, watch for further integration of AI and predictive algorithms in health diagnostics.

Signal Tracker Updates

Multi-omic blood panels are enabling personalized aging assessments (blood-biomarker-panels): 7 linked post(s) (supports: 3, contradicts: 0, mixed: 4, mentions: 0).
Epigenetic clocks are becoming standard biological age measures (epigenetic-clock-adoption): 7 linked post(s) (supports: 2, contradicts: 0, mixed: 5, mentions: 0).
Gene therapies targeting aging pathways are entering clinical development (gene-therapy-aging): 1 linked post(s) (supports: 0, contradicts: 0, mixed: 1, mentions: 0).
Microbiome composition is linked to aging trajectories (gut-microbiome-aging): 12 linked post(s) (supports: 1, contradicts: 0, mixed: 11, mentions: 0).
Senolytic therapies are showing clinical efficacy in human trials (senolytic-clinical-validation): 14 linked post(s) (supports: 3, contradicts: 1, mixed: 10, mentions: 0).
Sexual activity and sex hormones shape healthspan and lifespan (sex-healthspan-lifespan): 5 linked post(s) (supports: 3, contradicts: 0, mixed: 0, mentions: 2).